Document is current
Any future updates will be listed below
-
Authors
Tada, Hiroshi https://orcid.org/0000-0003-2670-8982
Miyashita, Minoru
Harada-Shoji, Narumi
Ebata, Akiko
Sato, Miku
Motonari, Tokiwa
Yanagaki, Mika
Kon, Tomomi
Sakamoto, Aru
Ishida, Takanori
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 26 September 2024
First Online: 28 October 2024
Declarations
:
: Payment or honoraria for lectures—HT: Chugai, Daiichi Sankyo, Pfizer, Eli Lilly, Eisai AstraZeneca, MSD, Takeda, and Kyowa Kirin; MM: Chugai, Pfizer, Eli Lilly, MSD, Eisai, Taiho and AstraZeneca; NH: Chugai, Daiichi Sankyo, Pfizer, Eli Lilly, Takeda, Novartis, Eisai, AstraZeneca, MSD and Kyowa Kirin; AE: Kyowa Kirin; TI: Chugai, Daiichi Sankyo, Pfizer, Eli Lilly; YH, MS, TM, MY, TK and AS have no conflicts of interest to declare.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
